Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.

Identifieur interne : 000130 ( PubMed/Curation ); précédent : 000129; suivant : 000131

Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.

Auteurs : Taylor Kain ; Patrick J. Lindsay ; Neill K J. Adhikari ; Yaseen M. Arabi ; Maria D. Van Kerkhove ; Robert A. Fowler

Source :

RBID : pubmed:32213260

Abstract

Available animal and cell line models have suggested that specific therapeutics might be effective in treating Middle East respiratory syndrome (MERS). We conducted a systematic review of evidence for treatment with pharmacologic and supportive therapies. We developed a protocol and searched 5 databases for studies describing treatment of MERS and deaths in MERS patients. Risk of bias (RoB) was assessed by using ROBINS-I tool. We retrieved 3,660 unique citations; 20 observational studies met eligibility, and we studied 13 therapies. Most studies were at serious or critical RoB; no studies were at low RoB. One study, at moderate RoB, showed reduced mortality rates in severe MERS patients with extracorporeal membrane oxygenation; no other studies showed a significant lifesaving benefit to any treatment. The existing literature on treatments for MERS is observational and at moderate to critical RoB. Clinical trials are needed to guide treatment decisions.

DOI: 10.3201/eid2606.200037
PubMed: 32213260

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32213260

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.</title>
<author>
<name sortKey="Kain, Taylor" sort="Kain, Taylor" uniqKey="Kain T" first="Taylor" last="Kain">Taylor Kain</name>
</author>
<author>
<name sortKey="Lindsay, Patrick J" sort="Lindsay, Patrick J" uniqKey="Lindsay P" first="Patrick J" last="Lindsay">Patrick J. Lindsay</name>
</author>
<author>
<name sortKey="Adhikari, Neill K J" sort="Adhikari, Neill K J" uniqKey="Adhikari N" first="Neill K J" last="Adhikari">Neill K J. Adhikari</name>
</author>
<author>
<name sortKey="Arabi, Yaseen M" sort="Arabi, Yaseen M" uniqKey="Arabi Y" first="Yaseen M" last="Arabi">Yaseen M. Arabi</name>
</author>
<author>
<name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name>
</author>
<author>
<name sortKey="Fowler, Robert A" sort="Fowler, Robert A" uniqKey="Fowler R" first="Robert A" last="Fowler">Robert A. Fowler</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32213260</idno>
<idno type="pmid">32213260</idno>
<idno type="doi">10.3201/eid2606.200037</idno>
<idno type="wicri:Area/PubMed/Corpus">000130</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000130</idno>
<idno type="wicri:Area/PubMed/Curation">000130</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000130</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.</title>
<author>
<name sortKey="Kain, Taylor" sort="Kain, Taylor" uniqKey="Kain T" first="Taylor" last="Kain">Taylor Kain</name>
</author>
<author>
<name sortKey="Lindsay, Patrick J" sort="Lindsay, Patrick J" uniqKey="Lindsay P" first="Patrick J" last="Lindsay">Patrick J. Lindsay</name>
</author>
<author>
<name sortKey="Adhikari, Neill K J" sort="Adhikari, Neill K J" uniqKey="Adhikari N" first="Neill K J" last="Adhikari">Neill K J. Adhikari</name>
</author>
<author>
<name sortKey="Arabi, Yaseen M" sort="Arabi, Yaseen M" uniqKey="Arabi Y" first="Yaseen M" last="Arabi">Yaseen M. Arabi</name>
</author>
<author>
<name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name>
</author>
<author>
<name sortKey="Fowler, Robert A" sort="Fowler, Robert A" uniqKey="Fowler R" first="Robert A" last="Fowler">Robert A. Fowler</name>
</author>
</analytic>
<series>
<title level="j">Emerging infectious diseases</title>
<idno type="eISSN">1080-6059</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Available animal and cell line models have suggested that specific therapeutics might be effective in treating Middle East respiratory syndrome (MERS). We conducted a systematic review of evidence for treatment with pharmacologic and supportive therapies. We developed a protocol and searched 5 databases for studies describing treatment of MERS and deaths in MERS patients. Risk of bias (RoB) was assessed by using ROBINS-I tool. We retrieved 3,660 unique citations; 20 observational studies met eligibility, and we studied 13 therapies. Most studies were at serious or critical RoB; no studies were at low RoB. One study, at moderate RoB, showed reduced mortality rates in severe MERS patients with extracorporeal membrane oxygenation; no other studies showed a significant lifesaving benefit to any treatment. The existing literature on treatments for MERS is observational and at moderate to critical RoB. Clinical trials are needed to guide treatment decisions.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32213260</PMID>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1080-6059</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>26</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2020</Year>
<Month>Mar</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Emerging infectious diseases</Title>
<ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2606.200037</ELocationID>
<Abstract>
<AbstractText>Available animal and cell line models have suggested that specific therapeutics might be effective in treating Middle East respiratory syndrome (MERS). We conducted a systematic review of evidence for treatment with pharmacologic and supportive therapies. We developed a protocol and searched 5 databases for studies describing treatment of MERS and deaths in MERS patients. Risk of bias (RoB) was assessed by using ROBINS-I tool. We retrieved 3,660 unique citations; 20 observational studies met eligibility, and we studied 13 therapies. Most studies were at serious or critical RoB; no studies were at low RoB. One study, at moderate RoB, showed reduced mortality rates in severe MERS patients with extracorporeal membrane oxygenation; no other studies showed a significant lifesaving benefit to any treatment. The existing literature on treatments for MERS is observational and at moderate to critical RoB. Clinical trials are needed to guide treatment decisions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kain</LastName>
<ForeName>Taylor</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lindsay</LastName>
<ForeName>Patrick J</ForeName>
<Initials>PJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Adhikari</LastName>
<ForeName>Neill K J</ForeName>
<Initials>NKJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arabi</LastName>
<ForeName>Yaseen M</ForeName>
<Initials>YM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Van Kerkhove</LastName>
<ForeName>Maria D</ForeName>
<Initials>MD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fowler</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Emerg Infect Dis</MedlineTA>
<NlmUniqueID>9508155</NlmUniqueID>
<ISSNLinking>1080-6040</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CoV</Keyword>
<Keyword MajorTopicYN="N">MERS</Keyword>
<Keyword MajorTopicYN="N">Middle East respiratory syndrome</Keyword>
<Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword>
<Keyword MajorTopicYN="N">antivirals</Keyword>
<Keyword MajorTopicYN="N">convalescent plasma</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">coronavirus infections</Keyword>
<Keyword MajorTopicYN="N">corticosteroids</Keyword>
<Keyword MajorTopicYN="N">interferon</Keyword>
<Keyword MajorTopicYN="N">intravenous immunoglobulin</Keyword>
<Keyword MajorTopicYN="N">respiratory infections</Keyword>
<Keyword MajorTopicYN="N">ribavirin</Keyword>
<Keyword MajorTopicYN="N">severe acute respiratory syndrome</Keyword>
<Keyword MajorTopicYN="N">supportive care</Keyword>
<Keyword MajorTopicYN="N">systematic review</Keyword>
<Keyword MajorTopicYN="N">viruses</Keyword>
<Keyword MajorTopicYN="N">zoonoses</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32213260</ArticleId>
<ArticleId IdType="doi">10.3201/eid2606.200037</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000130 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000130 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:32213260
   |texte=   Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:32213260" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021